Yirmibes, S. Et Al. 2023. CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?. JOURNAL OF CUTANEOUS PATHOLOGY , vol.50 , 56-61.

Yirmibes, S., BALABAN ADIM, Ş., & SARAYDAROĞLU, Ö., (2023). CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?. JOURNAL OF CUTANEOUS PATHOLOGY , vol.50, 56-61.

Yirmibes, Selin, ŞADUMAN BALABAN ADIM, And ÖZLEM SARAYDAROĞLU. "CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?," JOURNAL OF CUTANEOUS PATHOLOGY , vol.50, 56-61, 2023

Yirmibes, Selin Et Al. "CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?." JOURNAL OF CUTANEOUS PATHOLOGY , vol.50, pp.56-61, 2023

Yirmibes, S. BALABAN ADIM, Ş. And SARAYDAROĞLU, Ö. (2023) . "CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?." JOURNAL OF CUTANEOUS PATHOLOGY , vol.50, pp.56-61.

@article{article, author={Selin Yirmibes Et Al. }, title={CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?}, journal={JOURNAL OF CUTANEOUS PATHOLOGY}, year=2023, pages={56-61} }